This report contains market size and forecasts of Lung Cancer Diagnostics in Global, including the following market information:
Global Lung Cancer Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Lung Cancer Diagnostics market was valued at 1938 million in 2020 and is projected to reach US$ 2394.1 million by 2027, at a CAGR of 5.4% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lung Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Lung Cancer Diagnostics Market Segment Percentages, By Type, 2020 (%)
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other
China Lung Cancer Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Lung Cancer Diagnostics Market Segment Percentages, By Application, 2020 (%)
Industrial
Healthcare
Other
Global Lung Cancer Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Lung Cancer Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Lung Cancer Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Lung Cancer Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Roche Diagnostics
BioM?rieux
Qiagen
Advpharma
AIT Austrian Institute of Technology
Courtagen Life Sciences
DiagnoCure
BioMark Diagnostics
Mayo Clinic
HalioDx SAS
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Diagnostics Overall Market Size
2.1 Global Lung Cancer Diagnostics Market Size: 2021 VS 2027
2.2 Global Lung Cancer Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Diagnostics Players in Global Market
3.2 Top Global Lung Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Lung Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Lung Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Cancer Diagnostics Market Size Markets, 2021 & 2027
4.1.2 Immunoassays
4.1.3 Flow Cytometry
4.1.4 Rapid Tests
4.1.5 Molecular Assays
4.1.6 Tissue Arrays
4.1.7 Circulating Tumor Cells
4.1.8 Pharmacodiagnostics
4.1.9 Biomarkers
4.1.10 Other
4.2 By Type - Global Lung Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Diagnostics Revenue, 2016-2021
4.2.2 By Type - Global Lung Cancer Diagnostics Revenue, 2022-2027
4.2.3 By Type - Global Lung Cancer Diagnostics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Diagnostics Market Size, 2021 & 2027
5.1.2 Industrial
5.1.3 Healthcare
5.1.4 Other
5.2 By Application - Global Lung Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Diagnostics Revenue, 2016-2021
5.2.2 By Application - Global Lung Cancer Diagnostics Revenue, 2022-2027
5.2.3 By Application - Global Lung Cancer Diagnostics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Lung Cancer Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Lung Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Diagnostics Revenue, 2016-2021
6.2.2 By Region - Global Lung Cancer Diagnostics Revenue, 2022-2027
6.2.3 By Region - Global Lung Cancer Diagnostics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Lung Cancer Diagnostics Revenue, 2016-2027
6.3.2 US Lung Cancer Diagnostics Market Size, 2016-2027
6.3.3 Canada Lung Cancer Diagnostics Market Size, 2016-2027
6.3.4 Mexico Lung Cancer Diagnostics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Diagnostics Revenue, 2016-2027
6.4.2 Germany Lung Cancer Diagnostics Market Size, 2016-2027
6.4.3 France Lung Cancer Diagnostics Market Size, 2016-2027
6.4.4 U.K. Lung Cancer Diagnostics Market Size, 2016-2027
6.4.5 Italy Lung Cancer Diagnostics Market Size, 2016-2027
6.4.6 Russia Lung Cancer Diagnostics Market Size, 2016-2027
6.4.7 Nordic Countries Lung Cancer Diagnostics Market Size, 2016-2027
6.4.8 Benelux Lung Cancer Diagnostics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Diagnostics Revenue, 2016-2027
6.5.2 China Lung Cancer Diagnostics Market Size, 2016-2027
6.5.3 Japan Lung Cancer Diagnostics Market Size, 2016-2027
6.5.4 South Korea Lung Cancer Diagnostics Market Size, 2016-2027
6.5.5 Southeast Asia Lung Cancer Diagnostics Market Size, 2016-2027
6.5.6 India Lung Cancer Diagnostics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Lung Cancer Diagnostics Revenue, 2016-2027
6.6.2 Brazil Lung Cancer Diagnostics Market Size, 2016-2027
6.6.3 Argentina Lung Cancer Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Diagnostics Revenue, 2016-2027
6.7.2 Turkey Lung Cancer Diagnostics Market Size, 2016-2027
6.7.3 Israel Lung Cancer Diagnostics Market Size, 2016-2027
6.7.4 Saudi Arabia Lung Cancer Diagnostics Market Size, 2016-2027
6.7.5 UAE Lung Cancer Diagnostics Market Size, 2016-2027
7 Players Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Corporate Summary
7.1.2 Roche Diagnostics Business Overview
7.1.3 Roche Diagnostics Lung Cancer Diagnostics Major Product Offerings
7.1.4 Roche Diagnostics Lung Cancer Diagnostics Revenue in Global (2016-2021)
7.1.5 Roche Diagnostics Key News
7.2 BioM
Roche Diagnostics
BioM